(Q39108154)

English

Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting system

scientific article published on 20 August 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting system (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Gerhard Ehninger

12

object named as

G Ehninger

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Martin Bornhäuser

11

object named as

M Bornhäuser

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

C Arndt

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

A Feldmann

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

M von Bonin

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

M Cartellieri

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

E-M Ewen

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

S Koristka

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

I Michalk

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

S Stamova

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

N Berndt

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

A Gocht

10

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

M Schmitz

13

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

M Bachmann

14

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

20 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

59-69

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Bispecific antibodies for cancer immunotherapy: Current perspectives

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapses

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Retargeting of T cells to prostate stem cell antigen expressing tumor cells: comparison of different antibody formats

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Current and emerging therapies for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

T lymphocytes can be effectively recruited for ex vivo and in vivo lysis of AML blasts by a novel CD33/CD3-bispecific BiTE antibody construct.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker module

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Retargeting of human regulatory T cells by single-chain bispecific antibodies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Identification of La ribonucleoproteins as a component of interchromatin granules

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Antitumor activity of an EpCAM/CD3-bispecific BiTE antibody during long-term treatment of mice in the absence of T-cell anergy and sustained cytokine release

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Combination of a bispecific antibody and costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Mode of cytotoxic action of T cell-engaging BiTE antibody MT110.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Engineered antibody fragments and the rise of single domains

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Redirection of T cells with a first fully humanized bispecific CD33–CD3 antibody efficiently eliminates AML blasts without harming hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.243

21 January 2018

Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell costimulus-independent and very efficacious inhibition of tumor growth in mice bearing subcutaneous or leukemic human B cell lymphoma xenografts by a CD19-/CD3- bispecific single-chain antibody construct

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of normal myeloid-associated antigens by acute leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/LEU.2013.243

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39108154&oldid=2202552139"